← All organizations

Grupo Español de Leucemia Linfocítica Crónica (GELLC)

Academic/Hospital

Also known as: GELLC (Grupo Español de Leucemia Linfocítica Crónica) | Grupo Español de Leucemia Linfocítica Crónica (GELLC)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 15, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (8 distinct, 3 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

NCT06926205Lead sponsorPhase 2May 15, 2024
NCT06521996Lead sponsorPhase 2Apr 26, 2024
NCT04608318CollaboratorPhase 3Dec 31, 2020

Details

Last known activity: May 15, 2024